VITAFOXO logo

VITAFOXO
VitaFOXO

0
Mkt Cap
$0.00
24H Volume
$1,537.81
FDV
$150,154.00
Circ Supply
0.00
Total Supply
10M
VITAFOXO Fundamentals
Max Supply
10M
7D High
$0.0155
7D Low
$0.0146
24H High
$0.0153
24H Low
$0.0148
All-Time High
$0.0606
All-Time Low
$0.0146
VITAFOXO Prices
VITAFOXO / USD
$0.015
VITAFOXO / EUR
€0.0128
VITAFOXO / GBP
£0.0111
VITAFOXO / CAD
CA$0.0204
VITAFOXO / AUD
A$0.0209
VITAFOXO / INR
₹1.41
VITAFOXO / NGN
NGN 20.34
VITAFOXO / NZD
NZ$0.0254
VITAFOXO / PHP
₱0.9125
VITAFOXO / SGD
SGD 0.0191
VITAFOXO / ZAR
ZAR 0.2477
Loading...
Loading...
News
all
press releases
<
...
1
>

Sentiment

Indicates whether most users posting on a symbol’s stream over the last 24 hours are fearful or greedy.
0
25
50
75
100
Extreme
Fear
Neutral
Greed
Extreme
Fear
Greed
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

Message Volume

Measures the total amount of chatter on a stream over the last 24 hours.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

Participation Ratio

Measures the number of unique accounts posting on a stream relative to the number of total messages on that stream.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

AboutThis project will design a new RNA therapeutic that nudges the longevity-linked FOXO3 gene into its health-promoting form to halt the tissue breakdown behind degenerative disc disease—opening a precise, scalable route to drugs that extend healthspan. Dr. Lorna Harries’ lab has identified an innovative way to modulate FOXO3, a well known and yet undrugged longevity target, and propose leveraging it to address chronic lower back pain stemming from degenerative disc disease. They plan to make short, lab-made modified RNA molecules (antisense oligonucleotides) that selectively switch FOXO3’s “good” message on, first in human cells and mini-disc models. Success would yield 1) a lead drug candidate, 2) proof it can restore disc health, and 3) the data needed for patenting and further development. The same molecules could later be adapted to treat many other age-related conditions, helping people stay healthy for longer.
Details
Categories
Base EcosystemDecentralized Science (DeSci)
Date
Market Cap
Volume
Close
April 27, 2026
$0.00
$1,537.81
---
April 27, 2026
$0.00
$295.66
---
April 26, 2026
$0.00
$374.49
$0.0149
April 25, 2026
$0.00
$1,058.21
$0.0151
April 24, 2026
$0.00
$3,346.67
$0.015
April 23, 2026
$0.00
$214.62
$0.0148
April 22, 2026
$0.00
$2,223.95
$0.0151
April 21, 2026
$0.00
$562.43
$0.0146
April 20, 2026
$0.00
$2,011.36
$0.015
April 19, 2026
$0.00
$3,118.62
$0.0154

Poll

Will total altcoin market growth outpace Bitcoin in 2026? *Powered by CoinShares
Yes. Altcoins will outperform
No. Bitcoin leads gains
Roughly the same

Latest VITAFOXO News

Top Discussions

Advertisement|Remove ads.